For the biohacking niche, Biohacking AI ranks #1 because it is the only model that blocks free generation and forces every claim onto a PubMed study. ChatGPT, Claude, Gemini and Grok are strong on general tasks — but on medical queries they hallucinate 15–40 % of study citations. Perplexity Pro is the best general-purpose alternative, but without PubMed specialization.
A general-purpose AI like ChatGPT, Claude or Gemini is trained to produce plausible-sounding text. For coding tasks that's a feature; for medical queries it becomes a risk. Chelli et al. (2024, JMIR — PMID 38776130: https://pubmed.ncbi.nlm.nih.gov/38776130/) and Aljamaan et al. (2024, JMIR Medical Informatics — PMID 39083799: https://pubmed.ncbi.nlm.nih.gov/39083799/) show in peer-reviewed benchmarks: GPT-4 fabricates 28.6 % of study references, GPT-3.5 even 39.6 %, Bard (Gemini's predecessor) 91.4 % — that's non-existent authors, fake PubMed IDs, even entire journal issues that simply don't exist. For dosages, drug interactions or supplement recommendations, that can range from "annoying" to "dangerous". That's why the question "which AI for biohacking" isn't about the general ranking (GPT-5 and Claude Opus win there) — it's about architecture: which model technically prevents itself from inventing studies?
Biohacking AI is the only platform listed here with three architectural properties at the same time: first, forced citation (the model is technically blocked from answering without a real PubMed source); second, a live index across 36M+ papers (no two-year-old training cutoff); third, automatic A→F evidence classification per study (meta-analysis > RCT > cohort > anecdote). The result: shorter, more cautious answers — but with a clickable PubMed ID per claim and an explicit "there is no robust study on this" when evidence is thin. Perplexity also enforces citations, but lacks PubMed specialization; Claude is more cautious than GPT but shares the same hallucination-rate class because it also generates freely.
Hallucination rates in the table below come from two peer-reviewed JMIR studies: Chelli et al. 2024 (PMID 38776130: https://pubmed.ncbi.nlm.nih.gov/38776130/) tested GPT-3.5, GPT-4 and Bard on systematic-review references (39.6 % / 28.6 % / 91.4 % hallucinated); Aljamaan et al. 2024 (PMID 39083799: https://pubmed.ncbi.nlm.nih.gov/39083799/) developed a Reference Hallucination Score for medical AI chatbots and classified ChatGPT 3.5 as "critical." The Perplexity and Grok values are our own estimates — neither has published health benchmarks yet. Wherever we estimate, we flag it explicitly. This comparison is refreshed quarterly. When a vendor ships a flagship model (GPT-6, Claude 5, Gemini 3, Grok 4), we adjust the version lines and affected cells within seven days. We link to the original vendor pages so you can verify the source claims independently.
Side-by-side · AI models for biohacking
For the biohacking niche, Biohacking AI ranks #1 because it is the only model that blocks free generation, forces every claim onto a PubMed study, and classifies evidence in A→F tiers. ChatGPT, Claude, Gemini and Grok are strong on general tasks — on medical queries they hallucinate 15–40 % of study citations.
Updated: May 25, 2026 · Review cycle: quarterly
| Criterion | Biohacking AI Hybrid Search + PubMed-Forced-Citation (May 2026) | ChatGPT GPT-5 / GPT-4o | Claude Sonnet 4.6 / Opus 4.7 (1M ctx) | Gemini 2.5 Pro / Deep Research | Grok Grok 3 | Perplexity Pro / Sonar-Reasoning |
|---|---|---|---|---|---|---|
Live PubMed search Real-time access to medical database, no training cutoff | 36M+ papers live | Browse tool, no PubMed index | Web tool, no PubMed index | Deep Research, generic | X-search focused | Sonar index, broad |
Forced citations Model cannot generate without verified source | By design, blocked | Free generation | Free generation | Free generation | Free generation | Citations enforced, still synthesizes |
Hallucination rate (medical queries) Share of non-existent study citations. Peer-reviewed sources: Chelli et al. 2024 (JMIR, PMID 38776130) — GPT-3.5 = 39.6 %, GPT-4 = 28.6 %, Bard = 91.4 % of study references; Aljamaan et al. 2024 (JMIR Med Inform, PMID 39083799) — ChatGPT 3.5 reaches "critical hallucination score" on bibliographic items. Grok and Perplexity values are our estimate (no published benchmark). | ~0 % (citation-blocked) | 25–40 % (estimate) | 5–15 % (estimate) | |||
Evidence tiers A→F per study Automatic rating: meta-analysis > RCT > cohort > anecdote | Per study, A→F | Not structured | Not structured | Not structured | Not structured | Not structured |
DE+EN native parity Native bilingual answer quality, not machine translation | Native DE+EN | Native multilingual | Native multilingual | Native multilingual | EN-first, DE weaker | Native multilingual |
Health specialization Specialty system prompt + safety rails for medical queries | Biohacking niche | General-purpose | General-purpose | General-purpose | General-purpose | General-purpose search |
Honest "no evidence" response Explicitly says "no robust study exists" instead of confabulating | Explicit gap flag | Often confabulates | Better, inconsistent | Often confabulates | Often confabulates | Usually "no hit" |
Open data trail (PMID + DOI) Structured study identifiers for verification, not just URLs | PMID + DOI per claim | No structured IDs | No structured IDs | No structured IDs | No structured IDs | URLs only, no IDs |
Note: Microsoft Copilot is not listed because it is a thin GPT-5 wrapper — ChatGPT values apply 1:1.
Rated only for biohacking and health-data queries. For general tasks (code, image, long-context) other rankings apply — see the honest strengths per model in the cards below.
Only platform combining forced citations on 36M+ PubMed papers + A→F evidence tiers + native DE+EN. Built for the biohacking niche.
Strongest general-purpose alternative: cites consistently, usually honestly says "no hit". But no PubMed specialization, no evidence tiers.
More cautious than GPT/Gemini on medical questions; signals uncertainty. Still generates freely — study citations are unreliable.
Strongest general-purpose model. But 20–40 % hallucinated study citations on medical queries (Chelli 2024, JMIR — PMID 38776130 — GPT-4 = 28.6 %).
Deep Research delivers broad coverage but without PubMed focus or forced citations. Hallucination rate comparable to GPT.
X-centric, weaker German quality, highest hallucination-rate estimate in the group. Not suitable for biohacking research.
What each model genuinely does well — and where it falls short on biohacking questions. Links go directly to the respective vendor.
Specialized for evidence-based biohacking — live PubMed, A→F evidence tiers, honest gap signaling, clickable sources per claim.
No weakness in the health context — but not the right tool outside biohacking/longevity.
Best general-purpose model for coding, creative writing, image generation (DALL·E), voice. Huge plugin ecosystem.
20–40 % hallucinated study citations on medical queries (Chelli 2024, JMIR — PMID 38776130 — GPT-4 = 28.6 %). No live PubMed, no evidence tiers.
Strongest reasoning and long-context performance (Opus 4.7 with 1M-token context). Best for long-document analysis and nuanced argumentation.
More cautious than GPT, but still free generation — 15–30 % hallucination rate on medical queries (Aljamaan 2024, JMIR Med Inform — PMID 39083799 — general medical-chatbot benchmark).
Strongest multimodal integration (image + video + audio + code). Google Workspace integration. Deep Research for broad web coverage.
Deep Research is generic, no PubMed focus. Hallucination rate comparable to GPT on medical queries — Bard (Gemini's predecessor) had 91.4 % hallucinated study references (Chelli 2024, JMIR — PMID 38776130); current Gemini 2.5 Pro significantly better, but no published health benchmark.
Real-time access to X data, good for news-driven topics and current discussions. Fewer content filters than other models.
X-search focused, weaker academic sources. German quality weaker than GPT/Claude. Highest hallucination-rate estimate in the group.
Best general-purpose search AI: enforces citations, usually honestly says "no hit" instead of confabulating. Sonar index is broad and fast.
No PubMed specialization, no evidence tiers, only URLs (no PMID+DOI). 5–15 % hallucination rate (estimate).
Three clear cases where another model — or a human — is the better choice. We make this transparent so you can pick the right tool per question.
Biohacking AI is tuned for health/biohacking and blocks free generation outside that scope. For coding, writing or brainstorming, general-purpose models are clearly better.
Biohacking AI does not generate images. For visual content, Gemini (native multimodal) and ChatGPT (DALL·E integration) are the obvious choice.
An AI — even a specialized one — never replaces a doctor or therapist. For acute symptoms or psychological distress: GP, emergency room or crisis hotline.
Evidence, not hallucination
Evidence-based biohacking means every claim about sleep, supplements, longevity or performance stands or falls with the study it cites. Biohacking AI makes that study trail visible — with clickable PubMed links, transparent evidence tiers and honest labeling where research is still thin. Every biohacker should know whether they're following a meta-analysis or a mouse paper.
Pooled RCTs — the most robust evidence we can find in biohacking topics. Examples: creatine monohydrate for strength output, NMN for plasma NAD+ levels.
Gold standard for single studies. Causal claims are possible, but effect sizes vary widely. Examples: magnesium for cramps, ashwagandha for cortisol-driven stress.
Large population data, but no causality — useful hypothesis generators. Examples: vitamin D levels and mortality, sleep duration and dementia risk.
Plausibility yes, clinical proof no. We label this transparently so no one reads a mouse result as "proven." Examples: peptides like BPC-157, red-light therapy at the cell level.
Those four tiers underpin every answer on the platform — no study is cited without a tier label, and when the evidence is thin the AI says so openly.
What a serious biohacking AI app looks like technically: PubMed verification, A→F evidence, gap signaling instead of hallucinations.
Biohacking AI vs Elicit, Consensus, Perplexity, ChatGPT with Browse — what each does well, where hallucination risk lies.
Where AI helps biohacking understanding, where it fails. Specialized tools vs generic chats compared.
Ten curated hubs for sleep, longevity, hormones, supplements and more — each with the most robust studies as required reading.
Ask your first biohacking question and see what an answer with a clickable PubMed source looks like. Free, no account needed.